Element Profile

Lutetium

Symbol

Lu

Atomic number

71

Group

Heavy rare earth

Properties

Density

9.84 g/cm³

Melting point

1663 °C

Boiling point

3402 °C

Crustal abundance

0.8 ppm

Supply Risk

Supply risk

High

Geological scarcity

Extreme

Primary economic driver

PET scanner crystals & Lu-177 cancer drugs

Overview

About Lutetium

Lutetium (Lu, atomic number 71) is the last of the lanthanides and one of the least abundant rare earths. Lutetium crystals detect radiation in PET scanners, and the isotope lutetium-177 is the active ingredient in approved cancer drugs. As of October 2026, China was the largest producer and had required export licenses for lutetium since April 2025.

What lutetium is

Lutetium is a hard, silvery metal and one of the heavy rare earth elements. As the final lanthanide, it has the highest melting point and density in the series according to Los Alamos National Laboratory. The U.S. Geological Survey puts its average abundance in Earth's crust at 0.8 parts per million. Among the naturally occurring lanthanides, only thulium is scarcer on those figures (USGS Professional Paper 1802-O).

The physical properties listed on this page are from the Royal Society of Chemistry periodic table.

Discovery and name

French chemist Georges Urbain reported lutetium in 1907 after finding it in a sample of ytterbium oxide. He named it after Lutetia, the Latin name for Paris. Austrian chemist Carl Auer von Welsbach and Charles James at the University of New Hampshire identified it at about the same time, and an international commission credited Urbain in 1909 (LANL). It was the last of the rare earths to be separated, and pure metal was first made in 1953, according to the RSC.

Why PET scanners use lutetium crystals

A PET scanner detects gamma rays given off inside the patient's body. Crystals ring the scanner and turn each gamma ray into a flash of light. Lutetium oxyorthosilicate (LSO) and LYSO, a version that also contains yttrium, are widely used for that job in modern PET detectors. They stop gamma rays well, give off a lot of light and respond quickly, according to a 2015 review by Qingyang Wei.

The same review notes one drawback. About 2.6% of natural lutetium is lutetium-176, which is slightly radioactive, so the crystals produce a low background signal that scanner designers have to manage.

Lutetium-177 in cancer treatment

Lutetium-177 is a radioactive isotope with a half-life of 6.7 days, used to treat neuroendocrine tumors and prostate cancer, according to Dutch isotope producer NRG|PALLAS. Each drug links the isotope to a molecule that binds to a protein on tumor cells.

  • Lutathera (lutetium Lu 177 dotatate). The U.S. Food and Drug Administration approved it in January 2018 for adults with somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (Oncology Nursing Society). In April 2024 the FDA extended it to pediatric patients 12 and older with the same tumors (FDA).
  • Pluvicto (lutetium Lu 177 vipivotide tetraxetan). The FDA approved it in March 2022 for adults with PSMA-positive metastatic castration-resistant prostate cancer who had already received hormone-pathway drugs and chemotherapy (Oncology Nursing Society). In March 2025 the FDA extended it to adults with PSMA-positive metastatic castration-resistant prostate cancer who had already received an androgen receptor pathway inhibitor, a type of hormone drug. Those patients also had to be considered appropriate to delay taxane-based chemotherapy (FDA). On July 31, 2026, the FDA approved it in combination with an androgen receptor pathway inhibitor for adults with PSMA-positive metastatic prostate cancer that is naive or sensitive to androgen pathway modulation. The FDA said this stage was previously called metastatic hormone-sensitive prostate cancer (FDA).

Research continues on other cancers. In August 2026, REEx covered an early human study pairing gallium-68 and lutetium-177 against kidney cancer that was still at the proof-of-concept stage.

Lutetium-177 is made in nuclear reactors, either by irradiating lutetium-176 or by irradiating ytterbium-176, which decays into lutetium-177 (NRG|PALLAS). The second route uses enriched ytterbium. Canadian firm Kinectrics said in May 2024 that the lutetium-177 supply chain had depended mostly on Russia. It said its new ytterbium-176 production would reduce that reliance.

Catalysts and research uses

Outside medicine, lutetium's main commercial use is as a catalyst for cracking hydrocarbons in oil refineries, according to the RSC. It has also been added to gadolinium gallium garnet crystals once used in magnetic bubble memory (LANL). Beyond those uses, the RSC says lutetium is little used outside research. Geologists use the slow decay of lutetium-176 into hafnium-176 to estimate the ages of meteorites and minerals (LANL).

Where lutetium comes from

Like the other rare earths, lutetium occurs mixed with its neighbors, mainly in monazite and alongside yttrium (RSC, LANL). Heavy rare earths are also concentrated in xenotime and ion-adsorption clays (USGS). USGS reports rare earth reserves for countries including China, Brazil, Australia and the United States, but it does not break out lutetium. Lutetium metal is difficult to extract (RSC). LANL says the cost of producing it is one reason its uses are limited.

Export controls and supply risk

On April 4, 2025, China placed lutetium under export licensing in MOFCOM Announcement No. 18, along with samarium, gadolinium, terbium, dysprosium, scandium and yttrium. In October 2025 China added holmium, erbium, thulium, europium and ytterbium to its controls, then suspended them in November 2025 before they took effect (CIRS). The April controls were not part of that suspension (USGS). As of October 2026, they remained in force.

USGS reported that every U.S. import of lutetium compounds and metals from 2021 through 2024 came from China, and U.S. net import reliance for heavy rare earths was 100% in 2025.

Supply outside China (as of October 2026)

In October 2025, Lynas Rare Earths announced a new heavy rare earth separation plant in Malaysia. Lutetium is in the plant's first set of products. Lynas forecast that capacity within two years, subject to regulatory approvals (Lynas). In July 2026, Lynas said it planned to bring lutetium, gadolinium and yttrium into production from 2027 to 2028, according to Shanghai Metals Market. As of October 2026, REEx found no public report of separated lutetium production outside China. Los Alamos National Laboratory lists Russia and Malaysia among producers without a date.

Recycling

The RSC puts lutetium's recycling rate below 10%. USGS does not report lutetium recycling separately; the heavy rare earths it says were recovered in 2025 came from permanent magnets.

What drives lutetium demand and supply

A 2015 study in the Journal of Sustainable Metallurgy found that lutetium had no high-volume uses and was produced in excess of demand and stockpiled. Lutetium-177 drugs are made from enriched isotopes in reactors. REEx's August 2026 coverage noted that isotope purity and reactor capacity matter more to that market than mine output. For bulk lutetium, the open question in the rare earth supply chain is whether separation outside China reaches steady output while China's licensing stays in place.

Frequently asked questions

What is lutetium used for?

Lutetium is used in LSO and LYSO crystals that detect radiation in PET scanners, as a catalyst for cracking hydrocarbons in oil refining, and in research. Its radioactive isotope lutetium-177 is the active ingredient in FDA-approved drugs for certain neuroendocrine tumors and prostate cancers.

How is lutetium-177 used in cancer treatment?

Lutetium-177 is attached to a molecule that binds to a protein on tumor cells, delivering radiation to those cells. The FDA has approved it in Lutathera for certain neuroendocrine tumors and in Pluvicto for PSMA-positive prostate cancer.

Why do PET scanners use lutetium?

PET scanners detect gamma rays with crystals that turn each ray into a flash of light. Lutetium-based crystals such as LSO and LYSO stop gamma rays well, give off a lot of light and respond quickly.

Where does lutetium come from?

Lutetium is recovered along with other rare earths from minerals such as monazite and xenotime and from ion-adsorption clays. China was the largest producer as of October 2026. All U.S. imports of lutetium compounds and metals from 2021 through 2024 came from China, according to USGS.

Does China restrict lutetium exports?

Yes. Since April 4, 2025, exporting lutetium and its metals, alloys, oxides and compounds from China has required a license under MOFCOM Announcement No. 18. Those April controls were not part of China's later suspension and remained in force as of October 2026.

Primary Uses

  • LSO/LYSO scintillator crystals for PET scanners
  • Lutetium-177 targeted radionuclide cancer therapy
  • Catalyst for hydrocarbon cracking in oil refining
  • Research, including lutetium-hafnium dating

Where It Is Mined and Processed

Mined in

Separated and processed in

Producing Projects

Companies

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here

Found in Products

REEx Intelligence

Recent Articles

Straight Into Your Inbox

Straight Into Your Inbox

Receive a Daily News Update Intended to Help You Keep Pace With the Rapidly Evolving REE Market.

Fantastic! Thanks for subscribing, you won't regret it.